Dr. Eriksson is a strategy, operations and board advisor working with some of the most innovative companies in Life Sciences. He is the former CEO and current Strategic Advisor at Trialbee, a leader in the digitization of clinical research whose clinical trial patient recruitment & enrollment platform is used across the industry in global clinical trials to help biopharmaceutical and medical device companies meet enrollment timelines.
An executive with extensive experience in clinical drug development at the clinic, sponsor and CRO levels including Merck & Co. Inc., PAREXEL and ICON. Dr. Eriksson is trained and skilled in clinical pharmacology, clinical research, clinical research operations with emphasis on health care alliances, site operations, feasibility, study start-up & implementation and patient recruitment. He is a strong business development and leadership professional with an innovative and creative mind to address clinical development challenges and realize new opportunities.
Dr. Eriksson is an Associate Professor in Clinical Pharmacology at Lund University, Sweden and at Rutgers University School of Health-Related Professionals in New Jersey, USA.
Marcus has been realizing innovative solutions and clinical science in the Pharma space for almost 20 years.
Passionate in driving operational value with technology, the science and the patient is always in focus.
As part of AstraZeneca’s Digital Health transformation, he is aiming to bring greater value to patients faster though technology.
Marcus is gearing up AstraZeneca’s capabilities to take on De-centralized trials, with patient centricity at heart.
Driven to change the ways we revel, Jen Batchelor brought her expertise of Ayurvedic practice, psychology, neuroscience, circadian rhythms, & quantum physics to concoct a tonic that would be the response to a long-unanswered need. She founded Kin Euphorics in 2017, bottling and canning a brain-powering combination of adaptogens, nootropics, and botanicals for anytime enjoyment. As the first Latinx woman to raise over $15 million in venture capital for a beverage brand, Jen has transformed Kin into a movement. The scientific foremother and pioneer of the nonalcoholic & consumables wellness category, Jen is forever dedicated to innovating for the betterment of all.
Serial, multi-award winning entrepreneur and founder of a portfolio of businesses in the FMCG / CPG sector, including marketing and advertising, logistics and fulfilment, print and merchandise production. He has recruited and led high-performing executive teams across several businesses from foundation to multi-million dollar annual revenues and award-winning standing in their respective industries.
In 2019, created and founded now the world’s largest, most widely available and most valuable non-alcoholic spirits company, Lyre’s Spirit Co. Lyre’s products have secured no less than 300 international wine and spirits awards in the first three years of availability and the prestigious non-alcoholic producer of the year in the New York Spirits Competition and a 2021 Spirited Award from the Tales of the Cocktail Foundation.
Mark’s background experience is marketing focused and bridges the client / agency divide, bringing a thorough understanding of marketing strategy development and brand commercialisation for the FMCG / CPG industry.
Zoey founded the Fungtional Brew Company with a desire to bring more functional herbs and fungi into the mainstream. Creating more mindful options for conscious consumers looking to reduce their alcohol consumption and empower their health. Zoey has been in the Hospitality industry for over 15 years, across bars, restaurants, events and as a venue and business owner. Her past role as a mindful drinking consultant opened up the world of no and low and this is where she saw the functional gap in the category. An entrepreneur with a passion for health and wellness, her brand Fungtn aims to bring functional drinking into the low alcohol, craft beer space.
